Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion

Spine

Volumn 30, Issue 15, 2005, Pages 1694-1698

  Glassman, Steven D ^a,b   Dimar, John R ^a   Carreon, Leah Y ^a   Campbell, Mitchell J ^a   Puno, Rolando M ^a   Johnson, John R ^a  

^a University of Louisville School of Medicine   (United States)

^b NONE   (United States)

Author keywords

Bone morphogenetic protein; Computed tomography scan assessment; Spinal fusion

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; AGED; ARTICLE; AUTOGRAFT; BONE GRAFT; BONE MATRIX; BONE RADIOGRAPHY; CLINICAL TRIAL; COMPRESSION RESISTANT MATRIX; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; ILIAC CREST; INSTRUMENTATION; INTERVERTEBRAL DISK DEGENERATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD COMPRESSION; SPINE FUSION; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; COLLAGEN; DRUG CARRIERS; DURAPATITE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SMOKING; SPINAL DISEASES; SPINAL FUSION; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 23244467021     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000172157.39513.80     Document Type: Article

References (32)

1. Arrington ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop 1996;329:300-9.
2. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine 1995;20:1055-60.
3. Goulet JA, Senunas LE, DeSilva GL, et al. Autogenous iliac crest bone graft. Clin Orthop 1997;339:76-81.
4. Vaccaro AR, Chiba K, Heller JG, et al. Bone grafting alternatives in spinal surgery. Spine J 2002;2:206-15.
5. Whang PG, Wang JC. Bone graft substitutes for spinal fusion. Spine J 2003; 3:155-65.
6. Weiner BK, Walker M. Efficacy of autologous growth factors in lumbar intertransverse fusions. Spine 2003;28:1968-70.
7. Burkus JK, Transfeldt EE, Kitchel SH, et al. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002;27:2396-408.
8. Burkus JR, Dorchak JD, Sanders DL. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine 2003;28:372-7.
9. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Spine 2000;25:376-81.
10. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trail: 2002 Volvo award in clinical studies. Spine 2002;27:2662-73.
11. Vaccaro AR, Anderson DG, Toth CA. Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion. Spine 2002;27(16 Suppl 1):S59-65.
12. Vaccaro AR, Patel T, Fischgrund J, et al. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2003;12:495-500.
13. Sandhu HS, Khan SN. Recombinant human bone morphogenetic protein-2: use in spinal fusion applications. J Bone Joint Surg Am 2003;85:89-95.
14. Martin GJ, Boden SK, Morone MA, et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose3, carrier, and safety. J Spinal Disord 1999; 12:179-86.
15. Suh DY, Boden SD, Louis-Ugbo J, et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine 2002;27:353-60.
16. Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003;23:429-34.
17. Johnsson R, Stromqvist B, Aspenberg P. Randomized radiosterometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human non-instrumented posterolateral lumbar fusion: 2002 Volvo award in clinical studies. Spine 2002;27:2654-61.
18. McKay B, Sandhu HS. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine 2002:27(16 Suppl 1):S66-85.
19. Seeherman H, Wozney J, Li R. Bone morphogenetic protein delivery systems. Spine 2002;27(16 Suppl 1):S16-23.
20. France JC, Yaszemski MJ, Lauerman WC, et al. A randomized prospective study of posterolateral lumbar fusion: outcomes with and without pedicle screw instrumentation. Spine 1999;24:553-60.
21. West JL III, Bradford DS, Ogilvie JW. Results of spinal arthrodesis with pedicle screw plate fixation. J Bone Joint Surg Am 1991;73:1179-84.
22. McGuire RA, Amundson GM. The use of primary internal fixation in spondylolisthesis. Spine 1993;18:1662-72.
23. Zdeblick TA. A prospective, randomized study of lumbar fusion: preliminary results. Spine 1993;18:983-91.
24. Glassman SD, Alegre G, Carteon L, et al. Perioperative complications in patients with diabetes mellitus treated by lumbar instrumentation and fusion. Spine J 2003;6:496-501.
25. Glassman SD, Anagnost SC, Parker A, et al. The effect of cigarette smoking and smoking cessation on spinal fusion. Spine 2000;20:2608-15.
26. Glassman SD, Rose SM, Dimar JR, et al. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 1998; 23:834-8.
27. Silcox HD, Boden SD, Schimandle JH, et al. Reversing the inhibitory6 effect of nicotine on spinal fusion using an osteoinductive protein extract. Spine 1993;23:291-6.
28. Luque E. Latest clinical results using demineralized bone materials and rhBMP-2: the Mexican experience. Read at Total Spine: Advanced Concepts and Constructs; Cancun, Mexico; 2002.
29. Santos ERG, Goss DG, Morcom RK, et al. Radiologic assessment of interbody fusion with cages. Spine 2003;28:997-1001.
30. Eck KR, Bridwell KH, Ungacta FF, et al. Analysis of Titanium Mesh Cages in Adults with Minimum Two-Year Follow-up. Spine 2000;25:2407-15.
31. Cizek GR, Boyd LM. Imaging pitfalls of interbody spinal implants. Spine 2000;25:2633-6.
32. Herzog RJ, Marcotte PJ. Assessment of spinal fusion. Critical evaluation of imaging techniques. Spine 1996;21:1114-8.